North America Patient Simulator Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Technology (Low-fidelity Simulators, Medium-fidelity Simulators, and High-fidelity Simulators), By Country and Growth Forecast, 2023 - 2029
The North America Patient Simulator Market would witness market growth of 7.6% CAGR during the forecast period (2023-2029).
Learners can practice their therapeutic, diagnostic, and decision-making abilities in an environment that is safe and under their direct supervision by using patient simulators, which can imitate various medical illnesses. As a result, they are an efficient instrument for enhancing the standard of care provided to patients and the level of safety provided by assisting in preparing medical personnel for actual clinical scenarios.
The growing emphasis on patient safety, which can be linked to an increase in the number of medical errors, is the primary driver driving the market. In addition, the robust presence of key companies producing advanced simulator technologies and an increase in activities by players in the organization of training programs for healthcare professionals are projected to boost the expansion of the market share. In addition, an increase in the number of initiatives done by different government agencies regarding reducing the frequency of medical errors and improving the abilities of healthcare professionals is likely to boost the expansion of the market.
Budget 2023 highlighted the government's plan to invest nearly $200 billion over ten years to strengthen Canada's universal public health care system. Over $77 billion will go to Ontario to support timely access to a family health team or provider, a sustainable health workforce, improved access to high-quality mental health services. Another common goal where cooperation is already in progress is helping Canadians age with dignity, close to home, and with access to home care or care in a secure long-term care facility. The high investment plans for an enhanced healthcare system, and better equipped and skilled healthcare staff is expected to surge the utilization and demand for the patient simulator to practice better and understand different procedures, thereby boosting the market growth in the region.
The US market dominated the North America Patient Simulator Market by Country in 2022 thereby, achieving a market value of $247.9 Million by 2029. The Canada market is exhibiting a CAGR of 9.7% during (2023 - 2029). Additionally, The Mexico market would experience a CAGR of 9.4% during (2023 - 2029).
Based on Type, the market is segmented into Adult Patient Simulator, Infant Simulator, and Childbirth Simulator. Based on End User, the market is segmented into Hospitals, and Academic Institutions. Based on Technology, the market is segmented into Low-fidelity Simulators, Medium-fidelity Simulators, and High-fidelity Simulators. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laerdal Medical Limited, CAE Inc., Gaumard Scientific Company, Inc., Kyoto Kagaku Co., Ltd., Medical-X, K.K. MedVision, Simulab Corporation, Limbs & Things Limited, Surgical Science Sweden AB, and Mentice AB.
Scope of the Study
Market Segments covered in the Report:
By Type
- Adult Patient Simulator
- Infant Simulator
- Childbirth Simulator
- Hospitals
- Academic Institutions
- Low-fidelity Simulators
- Medium-fidelity Simulators
- High-fidelity Simulators
- US
- Canada
- Mexico
- Rest of North America
- Laerdal Medical Limited
- CAE Inc.
- Gaumard Scientific Company, Inc.
- Kyoto Kagaku Co., Ltd.
- Medical-X
- K.K. MedVision
- Simulab Corporation
- Limbs & Things Limited
- Surgical Science Sweden AB
- Mentice AB
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Patient Simulator Market, by Type
- 1.4.2 North America Patient Simulator Market, by End User
- 1.4.3 North America Patient Simulator Market, by Technology
- 1.4.4 North America Patient Simulator Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. North America Patient Simulator Market by Type
- 3.1 North America Adult Patient Simulator Market by Country
- 3.2 North America Infant Simulator Market by Country
- 3.3 North America Childbirth Simulator Market by Country
- Chapter 4. North America Patient Simulator Market by End User
- 4.1 North America Hospitals Market by Country
- 4.2 North America Academic Institutions Market by Country
- Chapter 5. North America Patient Simulator Market by Technology
- 5.1 North America Low-fidelity Simulators Market by Country
- 5.2 North America Medium-fidelity Simulators Market by Country
- 5.3 North America High-fidelity Simulators Market by Country
- Chapter 6. North America Patient Simulator Market by Country
- 6.1 US Patient Simulator Market
- 6.1.1 US Patient Simulator Market by Type
- 6.1.2 US Patient Simulator Market by End User
- 6.1.3 US Patient Simulator Market by Technology
- 6.2 Canada Patient Simulator Market
- 6.2.1 Canada Patient Simulator Market by Type
- 6.2.2 Canada Patient Simulator Market by End User
- 6.2.3 Canada Patient Simulator Market by Technology
- 6.3 Mexico Patient Simulator Market
- 6.3.1 Mexico Patient Simulator Market by Type
- 6.3.2 Mexico Patient Simulator Market by End User
- 6.3.3 Mexico Patient Simulator Market by Technology
- 6.4 Rest of North America Patient Simulator Market
- 6.4.1 Rest of North America Patient Simulator Market by Type
- 6.4.2 Rest of North America Patient Simulator Market by End User
- 6.4.3 Rest of North America Patient Simulator Market by Technology
- Chapter 7. Company Profiles
- 7.1 Laerdal Medical Limited
- 7.1.1 Company Overview
- 7.1.2 Recent strategies and developments:
- 7.1.2.1 Partnerships, Collaborations, and Agreements:
- 7.1.2.2 Acquisition and Mergers:
- 7.2 CAE Inc.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Partnerships, Collaborations, and Agreements:
- 7.2.5.2 Product Launches and Product Expansions:
- 7.3 Gaumard Scientific Company, Inc.
- 7.3.1 Company Overview
- 7.3.2 Recent strategies and developments:
- 7.3.2.1 Product Launches and Product Expansions:
- 7.4 Kyoto Kagaku Co., Ltd.
- 7.4.1 Company Overview
- 7.5 Medical-X
- 7.5.1 Company Overview
- 7.6 K.K. MedVision
- 7.6.1 Company Overview
- 7.7 Simulab Corporation
- 7.7.1 Company Overview
- 7.8 Limbs & Things Limited
- 7.8.1 Company Overview
- 7.8.2 Recent strategies and developments:
- 7.8.2.1 Partnerships, Collaborations, and Agreements:
- 7.9 Surgical Science Sweden AB
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expenses
- 7.9.5 Recent strategies and developments:
- 7.9.5.1 Partnerships, Collaborations, and Agreements:
- 7.9.5.2 Acquisition and Mergers:
- 7.10. Mentice AB
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expenses
- 7.10.5 Recent strategies and developments:
- 7.10.5.1 Acquisition and Mergers:
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook